Search Tag: metastatic disease

Pharmacy Management

2015 27 Feb

Results of a Phase II study led by researchers in the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania show that Palbociclib, an oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast...Read more